Exploring Status of Oral Submucous Fibrosis and its Association with C-Reactive Protein at a Public Sector Medical University

OSMF and its Association with C-Reactive Protein

Authors

  • . kiran Department of Oral and Maxillofacial Surgery, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
  • Usman Manzoor Department of Oral and Maxillofacial Surgery, Avicenna Dental College, Lahore, Pakistan
  • Ali Raza Department of Health, Government of Sindh, Pakistan
  • Saba Parveen Department of Community Dentistry, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
  • Kashif Ali Channar Department of Oral and Maxillofacial Surgery, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
  • Abdullah . Department of Oral Medicine, Bhittai Dental and Medical College, Mirpurkhas, Pakistan
  • Salman Shams Department of Oral Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i02.553

Keywords:

C- Reactive Protein, Oral Submucous Fibrosis, Exploring

Abstract

Oral submucous fibrosis (OSMF) is a well-established precancerous condition affecting the oral mucosa. Objective: To explore serum C- reactive protein levels in healthy patients and their comparison with diagnosed patients having oral submucous fibrosis. Methods: Eighty-two patients of all age groups, irrespective of gender and clinically diagnosed with oral submucous fibrosis, without any other systemic problem were included in the study. Patients were divided into two groups i.e., Group A = normal healthy patients and Group B = clinically diagnosed oral submucous fibrosis patients. After taking detailed history of patients of both groups, blood samples were collected from all patients for C- reactive protein levels. Results: Out of 82 patients, male were 30 (73.2%) and 34 (82.9%) and female were 11 (26.8%) and 7 (17.1%) with mean age of 41.0 ± 6.6 years and 42.6 ± 7.4 years in group I (normal healthy patients) and group II (oral submucous fibrosis patients) respectively. All patients were long-term consumers of betel quid with or without tobacco [13 (31.7%) and 28 (68.3%)], whereas no healthy patient was using betel quid. CRP level was significantly high 3.62 ±1.02 mg/dl in OSMF patients as compared to normal healthy patients 0.40 ± 0.21mg/dl. Similarly, CRP level was significantly abnormal (raised) in all OSMF patients as compared to normal healthy patients where only 7 (17.1%) were reported with abnormal (raised) CRP levels. Conclusions: Serum C- reactive protein levels in oral submucous fibrosis patients were significantly high as compared to normal healthy patients.

References

Arakeri G and Brennan PA. Oral submucous fibrosis: an overview of the aetiology, pathogenesis, classification, and principles of management. British Journal of Oral and Maxillofacial Surgery. 2013 Oct; 51(7): 587-93. doi: 10.1016/j.bjoms.2012.08.014

Patil S and Maheshwari S. Proposed new grading of oral submucous fibrosis based on cheek flexibility. Journal of Clinical and Experimental Dentistry. 2014 Jul; 6(3): e255. doi: 10.4317/jced.51378

Gupta S, Singh R, Gupta OP, Tripathi A. Prevalence of oral cancer and pre-cancerous lesions and the association with numerous risk factors in North India: A hospital based study. National Journal of Maxillofacial Surgery. 2014 Jul; 5(2): 142. doi: 10.4103/0975-5950.154816

Hosein M, Mohiuddin S, Fatima N. Association between grading of oral submucous fibrosis with frequency and consumption of areca nut and its derivatives in a wide age group: a multi-centric cross sectional study from Karachi, Pakistan. Journal of Cancer Prevention. 2015 Sep; 20(3): 216. doi: 10.15430/JCP.2015.20.3.216

Javed F, Tenenbaum HC, Nogueira‐Filho G, Nooh N, O'Bello Correa F, et al. Periodontal inflammatory conditions among gutka chewers and non‐chewers with and without prediabetes. Journal of Periodontology. 2013 Aug; 84(8): 1158-64. doi: 10.1902/jop.2012.120390

Shafique K, Mirza SS, Vart P, Memon AR, Arain MI, Tareen MF, et al. Areca nut chewing and systemic inflammation: evidence of a common pathway for systemic diseases. Journal of Inflammation. 2012 Dec; 9(1): 1-8. doi: 10.1186/1476-9255-9-22

Khan MA, Siddqui HK, Hasan T, Bashir S. Prevalence of Areca Nut Eating Habits And Incidence Of Oral Submucosal Fibrosis In School Children--A Prospective Cross-Sectional Survey. Pakistan Oral & Dental Journal. 2014 Sep; 34(3): 462-6.

Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World Journal of Clinical Cases: WJCC. 2014 Dec; 2(12): 866. doi: 10.12998/wjcc.v2.i12.866

Wollina U, Verma SB, Faridi M, Patil K. Oral submucous fibrosis: an update. Clinical, Cosmetic and Investigational Dermatology. 2015 Apr; 2015: 193. doi: 10.2147/ccid.s80576

Kumar S. Oral submucous fibrosis: A demographic study. Journal of Indian Academy of Oral Medicine and Radiology. 2016; 28(2): 124. doi: 10.4103/0972-1363.195085

Hebbar PB, Sheshaprasad R, Gurudath S, Pai A, Sujatha D. Oral submucous fibrosis in India: Are we progressing??. Indian Journal of Cancer. 2014 Jul; 51(3): 222-6. doi: 10.4103/0019-509X.146724

ul Wahab N, Salima A, Muslim K, Shoaib K, Hassan M, Asifali S. Frequency and clinical presentation of oral submucous fibrosis. Pakistan Journal of Medicine and Dentistry. 2014; 3(04): 48-53.

Vankadara S, Padmaja K, Balmuri PK, Naresh G, Reddy V. Evaluation of serum C-reactive protein levels in oral premalignancies and malignancies: A comparative study. Journal of Dentistry (Tehran, Iran). 2018 Nov; 15(6): 358. doi: 10.18502/jdt.v15i6.329

Kumar CA and Bhateja S. Altered C-reactive protein levels in serum of oral precancer patients in comparison with healthy controls. International Journal of Oral & Maxillofacial Pathology. 2011 Oct; 2(4): 16-20.

Kaja S, Naga SK, Kumar KK, Dasari N, Kantheti LP, Reddy BV. Quantitative analysis of C-reactive protein in potentially malignant disorders: A pilot study. Journal of Orofacial Sciences. 2015 Jan; 7(1): 3-6. doi: 10.4103/0975-8844.157355

Tariq FA, Janjua OS, Khan U. C-Reactive Protein As A Prognostic Indicator Of Oral Squamous Cell Carcinoma-A Retrospective Study. Pakistan Oral & Dental Journal. 2011 Dec 1;31(2): 288-91.

Metgud R and Bajaj S. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma. Biotechnic & Histochemistry. 2016 Feb; 91(2): 96-101. doi: 10.3109/10520295.2015.1077393

Khan S, Sinha A, Kumar S, Iqbal H. Oral submucous fibrosis: Current concepts on aetiology and management–A review. Journal of Indian Academy of Oral Medicine and Radiology. 2018 Oct; 30(4): 407. doi: 10.4103/jiaomr.jiaomr_89_18

Pundir S, Saxena S, Aggarwal P. Oral submucous fibrosis a disease with malignant potential: report of two Cases. Journal of Clinical and Experimental Dentistry. 2010; 2: 215-8. doi: 10.4317/jced.2.e215

Kujan O, Mello FW, Warnakulasuriya S. Malignant transformation of oral submucous fibrosis: A systematic review and meta‐analysis. Oral Diseases. 2021 Nov; 27(8): 1936-46. doi: 10.1111/odi.13727

Kaja S, Naga SK, Kumar KK, Dasari N, Kantheti LP, Reddy BV. Quantitative analysis of C-reactive protein in potentially malignant disorders: a pilot study. Journal of Orofacial Sciences. 2015 Jan; 7(1):3-6. doi: 10.4103/0975-8844.157355

Shaikh AH, Ahmed S, Siddique S, Iqbal N, Hasan SM, Zaidi SJ, et al. Oral Submucous Fibrosis: Study of Cases Reported At Dow International Medical College Hospital In Karachi, Pakistan. The Professional Medical Journal. 2019 Feb; 26(02): 275-81. doi: 10.29309/TPMJ/2019.26.02.3100

Memon MA, Shaikh MS, Jaffery MH. Oral submucosal fibrosis in Rural Sindh. Journal of Liaqat University of Medical Health Sciences. 2015 Jan; 14(1): 44-7.

Gosavi SR and Torkadi AA. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study. Journal of Oral Maxillofacial Pathology. 2020 Jan; 24(1): 46-51. doi: 10.4103/jomfp.JOMFP_317_19

Ray JG, Chatterjee R, Chaudhuri K. Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities. Periodontology 2000. 2019 Jun; 80(1): 200-12. doi: 10.1111/prd.12277

Bhattacharjee K, Girish HC, Murgod S, Varsha VK, Nishanthi L, Sunder S. Comparison of Serum C-Reactive protein level in Oral potentially Malignant disorders and in healthy individuals. Research Journal of Pharmaceutical Biological And Chemical Sciences. 2016 Mar; 7(2): 1285-90.

Kohli S, Gharote H, Shinde CV. Estimation of serum c reactive protein in oral submucous fibrosis. Journal of Dental & Orofacial Research. 2021 Jan; 17(1): 6-11.

Downloads

Published

2023-02-28
CITATION
DOI: 10.54393/pjhs.v4i02.553
Published: 2023-02-28

How to Cite

kiran, ., Manzoor, U. ., Raza, A. ., Parveen, S. ., Ali Channar, K. ., ., A., & Shams, S. (2023). Exploring Status of Oral Submucous Fibrosis and its Association with C-Reactive Protein at a Public Sector Medical University: OSMF and its Association with C-Reactive Protein. Pakistan Journal of Health Sciences, 4(02), 71–75. https://doi.org/10.54393/pjhs.v4i02.553

Issue

Section

Original Article

Plaudit

Most read articles by the same author(s)